Continuing Medical Education
Cleveland Clinic Center for Continuing Education
The Center for Continuing Education is committed to sharing a wealth of knowledge with physicians, nurses, and other medical professionals worldwide for more than 80 years. Its objective is to provide high-quality, innovative educational programs that increase the knowledge of health care providers, resulting in improved patient outcomes.
American Society of Clinical Oncology (ASCO)
Featured Abstracts from the 2022 Annual Meeting
- Top Abstracts from ASCO 2022
- Trastuzumab Deruxtecan Outperforms Standard Treatment in Patients with HER2-Low Metastatic Breast Cancer
- Assessing the Benefit of Endocrine Therapy After Breast-Conserving Surgery in Patients with Ductal Carcinoma In Situ
- Study Examines Rate of Inherited Cancer Risk in Individuals with Melanoma
-
Study Explores Trends in Young-Onset Pancreatico-Biliary Adenocarcinoma
American Society for Radiation Oncology (ASTRO)
Featured Abstracts from the 2021 Annual Meeting
- 18F Fluciclovine PET CT Helps Distinguish Radiation Necrosis from Brain Tumor Progression
- Cognitive Function Remains Stable Following Concurrent Temozolomide-based Chemoradiation Therapy in Low-Grade Gliomas
- Biosignature Predicts Benefit of Adjuvant Radiotherapy in Patients With DCIS
- Optimizing Stereotactic Body Radiation Therapy for Pediatric Sarcoma
- Study Identifies Prognostic Subgroups in Cutaneous Squamous Cell Carcinoma
American Society of Hematology (ASH)
Featured Abstracts from the 2021 Annual Meeting
- Modified Drug Regimen May Reduce Risks in Allogeneic Hematopoietic Cell Transplant Patients
- Biomarkers Predict Outcomes of CAR T-Cell Therapy in Patients with Diffuse Large B-Cell Lymphoma
- Addition of CAEL-101 to Anti-Plasma Cell Dyscrasia Therapy May Have Long-Term Benefits in Patients with AL Amyloidosis
- Immune Checkpoint Inhibitors May Enhance Cancer-Associated Thrombosis
- New Drug Combination Can Extend the Lives of Older Patients with Ph+ Acute Lymphoblastic Leukemia
- Newly Identified Risk Factors Help Predict How Aplastic Anemia Can Become Malignant
